Related Experiment Videos
A case report of neuroleptic malignant syndrome
Shankar Srinivas Kuchibatla1, Sofia Akram Cheema, Kripa S Chakravarthy
1North Yorkshire and York PCT, Psychiatry, Briary Wing, Harrogate District Hospital, Lancaster Park Road, Harrogate HG2 7SX, UK.
Abstract:
A 32-year-old male patient with a history of treatment resistant paranoid schizophrenia developed neuroleptic malignant syndrome (NMS) during changeover of his antipsychotic medication from zuclopenthixol depot to clozapine. This case highlights the difficulties of cross-tapering two antipsychotics-that is, converting from a typical depot medication to an oral atypical antipsychotic.
Related Concept Videos
Alterations in Muscle Tone lll
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Multiple Sclerosis l: Introduction
Rocky Mountain Spotted Fever
Neural Regulation
Parkinson Disease l: Introduction